Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 26, 2023
Call it a sign of the times: negotiations around the creation of a new Loss and Damage Fund for climate are breaking down, with developing nations and advanced economies at a familiar impasse. The Loss and Damage Fund—a fund meant to compensate vulnerable countries for climate impacts—is supposed to...
CGD NOTES
October 13, 2023
A world on fire requires the multilateral development banks to be at center stage in creating an effective response and bringing diverse actors to support a shared agenda of transformative development. MDBs have a distinctive comparative advantage in playing a catalytic role in fostering government ...
Blog Post
October 05, 2023
At the urging of shareholders, the World Bank has pulled together a set of reform proposals to broaden the World Bank Group’s mission, stretch its balance sheet, and strengthen its impact. We looked at both the new Roadmap document and 2016's Forward Look document to assess whether the Evolution Roa...
Blog Post
October 05, 2023
Next week, finance ministers and other officials from around the world will descend on Marrakech for the World Bank and IMF annual meetings. Read on for a range of quick reactions from CGD's experts on what will happen next week, and what should happen—and how we get from one to the other.
Blog Post
September 27, 2023
The UK is, hopefully, coming out of its nadir in international development. This is marked by planned rises in development spend, an ambitious new international development white paper, a supportive Minister, and a new parliament in 2024. But before considering any proposal, future governments with ...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
POLICY PAPERS
September 05, 2023
The G20 is well placed to provide the leadership needed to ensure that research is a global public good by elevating the discourse on research publishing reform and acknowledging that this is not merely a niche concern for researchers but an important global challenge that underpins human progress.